Invizius
Invizius offers extra-corporeal treatments for patients that includes dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. Invizius develops H-Guard, an advanced hemocompatible coating capable of preventing foreign body reactions in the blood at the source. Invizius aims to revolutionize dialysis and other extracorporeal treatments.
Domain
invizius.com
Country
United KingdomIndustry
BiotechnologyEmployees
11-50
Last Funding
$1.3M
Founded
2017
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does Invizius use?+
Invizius uses 9 technologies including Cookie Control, Modernizr, Mustache.
What industry is Invizius in?+
Invizius operates in the Biotechnology industry.
Where is Invizius based?+
Invizius is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026